1596 related articles for article (PubMed ID: 32878468)
1. Severe Acute Respiratory Syndrome Coronavirus 2 Impact on the Central Nervous System: Are Astrocytes and Microglia Main Players or Merely Bystanders?
Murta V; Villarreal A; Ramos AJ
ASN Neuro; 2020; 12():1759091420954960. PubMed ID: 32878468
[TBL] [Abstract][Full Text] [Related]
2. Neurological Damage by Coronaviruses: A Catastrophe in the Queue!
Mishra R; Banerjea AC
Front Immunol; 2020; 11():565521. PubMed ID: 33013930
[TBL] [Abstract][Full Text] [Related]
3. Update on neurological manifestations of COVID-19.
Yavarpour-Bali H; Ghasemi-Kasman M
Life Sci; 2020 Sep; 257():118063. PubMed ID: 32652139
[TBL] [Abstract][Full Text] [Related]
4. Effects of the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) on the nervous system. What can we expect from SARS -CoV-2?
Monroy-Gómez J; Torres-Fernández O
Biomedica; 2020 Oct; 40(Supl. 2):173-179. PubMed ID: 33152201
[TBL] [Abstract][Full Text] [Related]
5. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.
Li YC; Bai WZ; Hashikawa T
J Med Virol; 2020 Jun; 92(6):552-555. PubMed ID: 32104915
[TBL] [Abstract][Full Text] [Related]
6. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports.
Najjar S; Najjar A; Chong DJ; Pramanik BK; Kirsch C; Kuzniecky RI; Pacia SV; Azhar S
J Neuroinflammation; 2020 Aug; 17(1):231. PubMed ID: 32758257
[TBL] [Abstract][Full Text] [Related]
7. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
[TBL] [Abstract][Full Text] [Related]
8. A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic.
Gulati A; Pomeranz C; Qamar Z; Thomas S; Frisch D; George G; Summer R; DeSimone J; Sundaram B
Am J Med Sci; 2020 Jul; 360(1):5-34. PubMed ID: 32620220
[TBL] [Abstract][Full Text] [Related]
9. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
[TBL] [Abstract][Full Text] [Related]
10. The emergence of a novel coronavirus (SARS-CoV-2) disease and their neuroinvasive propensity may affect in COVID-19 patients.
Yashavantha Rao HC; Jayabaskaran C
J Med Virol; 2020 Jul; 92(7):786-790. PubMed ID: 32320066
[TBL] [Abstract][Full Text] [Related]
11. Computing the Effects of SARS-CoV-2 on Respiration Regulatory Mechanisms in COVID-19.
Baig AM
ACS Chem Neurosci; 2020 Aug; 11(16):2416-2421. PubMed ID: 32600045
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 and the Nervous System: From Clinical Features to Molecular Mechanisms.
Pennisi M; Lanza G; Falzone L; Fisicaro F; Ferri R; Bella R
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751841
[TBL] [Abstract][Full Text] [Related]
13. COVID-19, SARS and MERS: A neurological perspective.
Ng Kee Kwong KC; Mehta PR; Shukla G; Mehta AR
J Clin Neurosci; 2020 Jul; 77():13-16. PubMed ID: 32417124
[TBL] [Abstract][Full Text] [Related]
14. Similarities and Differences of Early Pulmonary CT Features of Pneumonia Caused by SARS-CoV-2, SARS-CoV and MERS-CoV: Comparison Based on a Systemic Review.
Chen X; Zhang G; Hao SY; Bai L; Lu JJ
Chin Med Sci J; 2020 Sep; 35(3):254-261. PubMed ID: 32972503
[TBL] [Abstract][Full Text] [Related]
15. The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries.
Román GC; Spencer PS; Reis J; Buguet A; Faris MEA; Katrak SM; Láinez M; Medina MT; Meshram C; Mizusawa H; Öztürk S; Wasay M;
J Neurol Sci; 2020 Jul; 414():116884. PubMed ID: 32464367
[TBL] [Abstract][Full Text] [Related]
16. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
[TBL] [Abstract][Full Text] [Related]
17. Infectivity of human coronavirus in the brain.
Cheng Q; Yang Y; Gao J
EBioMedicine; 2020 Jun; 56():102799. PubMed ID: 32474399
[TBL] [Abstract][Full Text] [Related]
18. Neuroinvasive potential of a primary respiratory pathogen SARS- CoV2: Summarizing the evidences.
Lahiri D; Mondal R; Deb S; Bandyopadhyay D; Shome G; Sarkar S; Biswas SC
Diabetes Metab Syndr; 2020; 14(5):1053-1060. PubMed ID: 32640417
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2, More than a Respiratory Virus: Its Potential Role in Neuropathogenesis.
Singal CMS; Jaiswal P; Seth P
ACS Chem Neurosci; 2020 Jul; 11(13):1887-1899. PubMed ID: 32491829
[TBL] [Abstract][Full Text] [Related]
20. Neurological manifestations and comorbidity associated with COVID-19: an overview.
Kumar M; Thakur AK
Neurol Sci; 2020 Dec; 41(12):3409-3418. PubMed ID: 33052573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
